×
For best experience we recommend to activate Javascript in your browser.
Recombinant CD40 Ligand antibody (Extracellular Domain)
This Mouse Monoclonal antibody specifically detects CD40 Ligand in BP. It exhibits reactivity toward Human.
Quick Overview for Recombinant CD40 Ligand antibody (Extracellular Domain) (ABIN7541079)
Target
See all CD40 Ligand (CD40LG) Antibodies
CD40 Ligand (CD40LG)
Antibody Type
Recombinant Antibody
Reactivity
All reactivities for CD40 Ligand antibodies
Human
Host
All hosts for CD40 Ligand antibodies
Mouse
Clonality
All clonalities for CD40 Ligand antibodies
Monoclonal
Conjugate
All conjugates for CD40 Ligand antibodies
This CD40 Ligand antibody is un-conjugated
Application
All applications for CD40 Ligand antibodies
Blocking Peptide (BP)
Clone
Chi220chi220
Product Details anti-CD40 Ligand Antibody
(hide)
Binding Specificity
All epitopes for CD40 Ligand antibodies
Extracellular Domain
Expression System
Mammalian cells
Purpose
Mouse recombinant monoclonal antibody raised against human CD40LG.
Cross-Reactivity
Human
Immunogen
Original antibody is raised against a fusion protein containing extracellular domain of human CD40 fused to the hinge CH2 and CH3 domains of a murine IgG2b antibody.
Isotype
IgG2a
Alternatives
(show)
Application Details
(hide)
Application Notes
Blocking,The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
In PBS (0.02 % Proclin 300)
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Store at 4°C for 3 months. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Target Details for CD40 Ligand
(hide)
Target
CD40 Ligand (CD40LG)
Alternative Name
CD40LG
Background
CD40 ligand
Gene ID
959
Pathways
NF-kappaB Signaling , Production of Molecular Mediator of Immune Response , Cancer Immune Checkpoints
Recently viewed
(hide)
Chat with us , powered by LiveChat